Clostridium sordellii infection in medical abortion

Clinical Infectious Diseases

Volumn 43, Issue 11, 2006, Pages 1447-1448

  Winikoff, Beverly ^a  

^a GYNUITY HEALTH PROJECTS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; MIFEPRISTONE; MISOPROSTOL;

ANTIBIOTIC PROPHYLAXIS; BACTERIAL COLONIZATION; BACTERIAL INFECTION; CHILDBIRTH; CLOSTRIDIUM SORDELLII; DEATH; HUMAN; INDUCED ABORTION; INFECTION RATE; NONHUMAN; NOTE; PRIORITY JOURNAL; SIDE EFFECT; SPONTANEOUS ABORTION; VAGINA;

ABORTIFACIENT AGENTS; ABORTION, INDUCED; CLOSTRIDIUM INFECTIONS; CLOSTRIDIUM SORDELLII; FEMALE; HUMANS; MIFEPRISTONE; MISOPROSTOL; PREGNANCY;

EID: 33751582718     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/508895     Document Type: Note

References (5)

1. Aldape MJ, Bryant AE, Stevens DL. Clostridium sordellii infection: epidemiology, clinical findings, and current perspectives on diagnosis and treatment. Clin Infect Dis 2006; 43:1436-46 (in this issue).
2. Fischer M, Bhatnagar J, Guarner J, et al. Fatal toxic shock syndrome associate with Clostridium sordellii after medical abortion. N Engl J Med 2005; 353:2352-60.
3. Hammill HA. Normal vaginal flora in relation to vaginitis. Obstet Gynecol Clin North Am 1989; 16:329-36.
4. Hatheway CL. Toxigenic clostridia. Clin Microbial Rev 1990; 3:66-98.
5. Shannon C, Brothers LP, Philip NM, Winikoff B. Infection after medical abortion: a review of the literature. Contraception 2004; 70:183-90.